Longevity · LOT 2025-01
FOXO4-DRI
€219/ 10mg vialIn stock
D-retro-inverso FOXO4 peptide that disrupts FOXO4–p53 binding; a key tool compound in senolytic research.
Request COA →
≥99.0% purityThird-party testedBatch documented
⚠ For research use only · Not for human use · Not FDA approved
Batch specifications
Purity99.0% by HPLC
FormLyophilized powder
Molecular WeightSee COA
StorageRefrigerate 2–8 °C
ReconstitutionSee COA
DocumentationCOA available
CategoryLongevity
TagsLongevity · Research · Peptide
Amino acid sequence
Sequence available on COA request.